Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 27th World Congress on Diet, Nutrition and Obesity Auckland, New Zealand.

Day 1 :

Keynote Forum

Lynnette Ferguson

University of Auckland, New Zealand

Keynote: Why would nutri-genomics be of value in studies of inflammatory bowel diseases

Time : 09:00-09:45

Conference Series Diet Congress 2018 International Conference Keynote Speaker Lynnette Ferguson photo
Biography:

Lynnette Ferguson has completed her Doctor of Philosophy studying at Oxford University. She returned to Auckland, New Zealand, to take on a Post-doctoral position. She initially worked solely as a Member of the Auckland Cancer Society Research Centre, but in the year 2000 took on a half time position as Professor and head of the Department of Nutrition. She has published more than 300 papers in reputed journals and book chapters.

Abstract:

Inflammatory bowel diseases have traditionally been considered to consist of two diff erent forms, Crohn’s disease and ulcerative colitis. A genetic component was recognized for many years, with early studies prior to the year 2000, suggesting between 4-8 genes as being causal. However, it is largely through substantial international progress in methods for genotyping, and also the formation of large international consortia, especially the international IBD genetics consortium, that has progress the science to show to show signifi cantly more than 100 genes, that determine the dietary requirements and the dietary intolerances. It seems highly likely that it should be classed as three rather than two diseases and genetics may be an important feature in determining treatment protocols.

Keynote Forum

Bruce D Given

Arrowhead Pharmaceuticals Inc., USA

Keynote: Hepatitis B in focus: New biology, new targets and real hope for fi nite therapy

Time : 09:45-10:30

Conference Series Diet Congress 2018 International Conference Keynote Speaker Bruce D Given photo
Biography:

Bruce D Given has served as COO of Arrowhead Pharmaceuticals since 2011. He has retired as Chairman of the Board for ICON, plc in 2013. He was with Johnson & Johnson for 9 years, with assignments including President, International, Ortho-Clinical Diagnostics and Head of US Marketing & Sales and Research & Development for Janssen Pharmaceutical. He has received his MD with honors from the University of Chicago, completed his Medical Training at University of Chicago and Brigham and Women’s Hospital, where he was Clinical Fellow at Harvard Medical School and was on the medical faculty at University of Chicago.

 

Abstract:

Drug development work in Chronic Hepatits B (CHB) has been largely stagnant for the last decade or more. While solid epidemiology work has demonstrated that seroclearance of HbsAg (functional cure) is associated with greatly reduced risk of cirrhosis or HCC, neither interferon therapy nor long-term nucleos(t)ide therapy are associated with meaningful rates of functional cure. With the recent successes achieved in curative treatment of Hepatitis C, the field has returned to curative eff orts in CHB and there has been an explosion of pre-clinical drug development against novel targets. As part of this process, new insights have been gained regarding the biology of CHB. This talk will focus on how these new biological insights are translating into new drug discovery eff orts, how these new drug classes are performing in the clinic, and the expected role for combining these drugs to achieve meaningful rates of functional cure with finite therapy.

 

Keynote Forum

Jay-Lin Jane

Iowa State University, USA

Keynote: Resistant starch: Structure, properties, processing and health benefits

Time : 10:45-11:30

Conference Series Diet Congress 2018 International Conference Keynote Speaker Jay-Lin Jane photo
Biography:

Jay-Lin Jane is a Charles F Curtiss Distinguished Professor, Emeritus in the Department of Food Science and Human Nutrition, Iowa State University. She has received her Bachelor’s degree from National Chung-Hsing University in Taiwan, Master’s degree from Texas Woman’s University and PhD degree from the Department of Biochemistry and Biophysics at Iowa State University. Her primary research interests are in starch structures, properties, applications, effects of resistant starch on health and biopolymers. She has published 215 referred publications and 10 patents with 10,000 citations and an h-index 53. She has received numerous awards, including the Alsberg-French-Schoch Award, the highest award for starch research, and a Fellow Award from the American Association of CerealChemists, International, the Merit of Science Award from the Japanese Applied Glyco-science Association and the Distinguished Faculty Award from Iowa State

 

Abstract:

Type-2 diabetes and related health problems, including obesity are results of over consumption of sugar and rapidly digestible starch. After ingesting foods of high-glycemic index, such as breakfast cereal and bread, the blood glucose level of the individual increases quickly and reaches a peak in 30 min, resulting in a hyper-glycemic state. Insulin secreted with the increase in the blood glucose level triggers the absorption of glucose from the blood stream and causes a hypo-glycemic response, repeating of these processes results in insulin resistance and the type-2 diabetes. Methods to prevent the type-2 diabetes are to reduce the intake of rapidly digestible carbohydrates, replace rapidly digestible starch with resistant and slowly digestible starch and increase vegetable and dietary fiber portion in the diet. There are five types of resistant starch, i.e. physically inaccessible starch, the B-type crystalline starch, retrograded amylose, chemically modified starch and the amylose-lipid complex. This presentation includes structures and properties of diff erent types of resistant starch, approaches available to facilitate the formation and increase the contents of resistant and slowly digestible starch by selecting ingredients and proper cooking methods and effects of ingesting resistant starch on levels of blood glucose and insulin secretion comparing with the normal starch as control. Different types of resistant starch have also shown characteristic impacts to microbiota developments in the gut and infl uence animal behavior. Resistant and slowly digestible starch has demonstrated health benefits. Therefore, it is important to select healthy starchy foods and proper processing methods to preserve and increase resistant starch contents in the diet.

  • Special Session
Location: Wink @ Naumi Hotel Auckland Airport

Session Introduction

Vikas Leelavati Balasaheb Jadhav

Dr. D. Y. Patil University, India

Title: Transabdominal sonography of the small and large intestines

Time : 11:30-12:30

Speaker
Biography:

Vikas Leelavati Balasaheb Jadhav has completed PostGraduation in Radiology in 1994. He has a 23 Years of experience in the field of Gastro-Intestinal Tract Ultrasound & Diagnostic as well Therapeutic Interventional Sonography. He is the Pioneer of Gastro-Intestinal Tract Sonography, especially Gastro-Duodenal Sonography. He has delivered many Guest Lectures in Indian as well International Conferences in nearly 27 countries as an Invited Guest Faculty, since March 2000. He is a Consultant Radiologist & the Specialist in Conventional as well Unconventional Gastro-Intestinal Tract Ultrasound & Diagnostic as well Therapeutic Interventional Sonologist in Pune, India.

 

Abstract:

Transabdominal Sonography of the Small & Large Intestines can reveal following diseases. Bacterial & Viral Entero-Colitis. An Ulcer, whether it is superficial, deep with risk of impending perforation, Perforated, Sealed perforation, Chronic Ulcer & Post-Healing fibrosis & stricture. Polyps & Diverticulum. Benign intra-mural tumours. Intra-mural haematoma. Intestinal Ascariasis. Foreign Body. Necrotizing Entero-Colitis. Tuberculosis. Intussusception. Inflammatory Bowel Disease, Ulcerative Colitis, Cronhs Disease. Complications of an Inflammatory Bowel Disease – Perforation, Stricture. Neoplastic lesion is usually a segment involvement, & shows irregularly thickened, hypoechoic & aperistaltic wall with loss of normal layering pattern. It is usually a solitary stricture & has eccentric irregular luminal narrowing. It shows loss of normal Gut Signature. Enlargement of the involved segment seen. Shouldering effect at the ends of stricture is most common feature. Primary arising from wall itself & secondary are invasion from adjacent malignancy or distant metastasis. All these cases are compared & proved with gold standards like surgery & endoscopy. Some extra efforts taken during all routine or emergent ultrasonography examinations can be an effective non-invasive method to diagnose primarily hitherto unsuspected benign & malignant Gastro-Intestinal Tract lesions, so should be the investigation of choice.

 

  • Sessions: Medications and Gastrointestinal diseases | Irritable Bowel Syndrome | Gallbladder Agenesis | Gallstone Pancreatitis | Nutrigenomics | Obesity Epidemiology
Location: Wink @ Naumi Hotel Auckland Airport
Speaker

Chair

Lynnette Ferguson

University of Auckland, New Zealand

Speaker

Co-Chair

Bruce D Given

Arrowhead Pharmaceuticals, USA

Session Introduction

Céline Tiffon

University Hospital Bern, Switzerland

Title: Histone deacetylase inhibition restores expression of hypoxia-inducible protein NDRG1 in pancreatic cancer

Time : 13:30-14:00

Speaker
Biography:

Céline Tiffon has completed her PhD in Tumor Biology from the University of Bern in 2007 and Postdoctoral studies from the United Kingdom and France where she has been working since 2010.

 

Abstract:

Pancreatic ductal adenocarcinoma, the most common subtype of human pancreatic cancer, affects both men and women and is highly aggressive, with a five-year survival rate of only about 5%. N-myc Downstream-Regulated Gene-1 (NDRG1) is a hypoxia-inducible and differentiation-related protein and candidate biomarker in pancreatic cancer. As NDRG1 expression is lost in high-grade tumors, the effects of the differentiating histone deacetylase inhibitor trichostatin A (TSA) were examined in human pancreatic cancer cell lines representing different tumor grades. Panc-1 (poorly differentiated) and Capan-1 (moderately- to well-differentiated) cells were treated with TSA. Effects were assessed in vitro by microscopic analysis, colorimetric assays, cell counts, real-time polymerase chain reaction, and western blotting. Treatment of Panc-1 cells over four days with 0.5 µM TSA restored cellular differentiation, inhibited proliferation, and enhanced p21Cip1 protein expression. TSA upregulated NDRG1 mRNA and protein levels under normoxia from day one and by six-fold by day four (p<0.01 at all-time points). After 24 h under hypoxia, NDRG1 expression was further increased in differentiated cells (p<0.01). Favorable changes were identified in the expression of other hypoxia-regulated genes. HDAC inhibitors offer a potential novel epi-drug approach for pancreatic cancer by reversing the undifferentiated phenotype and allowing patients to overcome resistance and better respond to conventional cytotoxic treatments. Restoration of NDRG1 expression may represent a biomarker of malignant pancreatic tumors undergoing re-differentiation and redirecting toward a lower tumor grade. The use of the human ductal Panc-1 cell line treated with TSA represents a useful tool to study cellular differentiation through epigenetic mechanisms.

 

Speaker
Biography:

Derouiche Abdelfettah has received a PhD in Bio-industry from the University of Nancy France in 1988 and PhD in Human Nutrition in 2008, Hassan University II Casablanca Morocco. He is the Professor in Human Nutrition and is a Director of the human nutrition research unit. He is a Temporary adviser on nutrition of WHO and the Head of Moroccan action on salt and health (MASH).

Abstract:

Statement of the Problem: Non-communicable diseases (NCDs) are not just a public health problem, they are also economical. These diseases are accentuated in the part of the population facing economic challenges and often resulting from rural exodus. The results of the (NCD) screenings in the city of Casablanca Morocco showed a high frequency of obesity and possible undiagnosed cases of NCD in low and middle-income areas. This study aimed to evaluate the prevalence of obesity among women in Casablanca and to study the factors involved.

Method: A survey was conducted in six Casablanca neighborhoods using multi-stage cluster sampling. Anthropometric parameters and body composition were measured and information on the evolution of eating habits, socio-demographic status and body image perception and use of fattening products was collected using a questionnaire of 425 adult women from the neighborhoods of Casablanca.

Result: We found a prevalence of 47% obesity and 36% overweight. Obesity and overweight exceeded 80% in all age groups, except for women under 25, where we found a prevalence of 44% overweight. In addition, the prevalence of abdominal obesity was high in all age groups with an overall prevalence of 67%. Body image perception data showed that 62% of women perceived their weight as normal or insufficient, 46% of these women were, in fact, overweight or obese. Fattening products have been used at least once by 12% of the population, especially by women under 35 years of age.

Conclusion: The problem of overweight and obesity in this society exceeds twice the national prevalence it would be in addition to the change in eating behavior and lifestyle to the perception of a regular weight and the use of fattening substances.

Yerimova N Zh

National Scientific Center of Surgery, Republic of Kazakhstan

Title: Our experience of prevention and treatment of cytomegalovirus infection in children after transplantation of the liver

Time : 14:30-15:00

Speaker
Biography:

Yerimova N Zh, Gastroenterologist of  Syzganov’s  National Scientific Center of  Surgery. Her research interest includes Gastroenterology, children liver transplantation and general pediatrics, scientific research, stem cell.

 

Abstract:

Aim: Evaluation of the effectiveness of the prevention of the treatment of cytomegalovirus infection after liver transplantation in children under 1 year of age with biliary atresia.

Material & Methods: Since March 2016 18 liver transplants from a living related donor in children were performed. The age of the patients ranged from 7 months to 8 years. Of these 15 (83.3%) patients were with biliary atresia. The number of girls is 10 (66.7%) and boys 5 (33.3%). At the time of diagnosis, most of the children registered formed cirrhosis of the liver.

Results: All recipients with positive quantitative parameters of PCR received CMV-specific immunoglobulin 3-5 months before the operation. The left lateral sector was transplanted to 15 patients with biliary atresia from CMV of the seropositive related lifelong donor (D+/R+) 13 donors and from CMV 1 seronegative donor (D-/R+), 1 to the simultaneous transplantation (liver and kidney) 2 patients with cirrhosis of the liver in the outcome of autoimmune hepatitis. In all children, biliary atresia was combined with a cytomegalovirus infection, 7 of them with an active form. The observation period is from 14 days after the operation to 2 years. After the operation, a three-component immunosuppressive therapy was performed (prednisolone, Sellsept, Tacrolimus). Activation was noted in 2 patients with inactive form of CMV. In 2 children, neurologic symptoms developed - 1 with active form of CMV and in 1 child it was associated with a toxic effect of immunosuppressive therapy (tacrolimus), which was managed by conservative methods of treatment. All children with cytomegalovirus infection received antiviral therapy with valganciclovir at a rate of 18 mg/kg for 1 month, against which the virus load in children with an active CMV phase was reduced. Six months after the operation, in all children, the quality of PCR for CMV was negative. At 9 months after liver transplantation, 1 patient with an inactive form of CMV had an increase in viral load.

Conclusions: Thus, our experience once again confirms the role of cytomegalovirus infection in the development of biliary atresia with the formation of liver cirrhosis and requires adequate follow-up after liver transplantation.

 

Jessica Danaher

Royal Melbourne Institute of Technology University, Australia

Title: Using nutritional genomics in nutrition practice: Current evidence and future directions

Time : 15:15-15:45

Speaker
Biography:

Jessica Danaher has completed her PhD at Victoria University in Human Obesity Genetics and Skeletal Muscle Metabolism using nutrition and exercise stressors. She also pursued Masters of Dietetics at Deakin University and is now an Accredited Practicing Dietitian. Her previous roles include Clinical Dietitian at St Vincent's Hospital, Casual Research Fellow at Deakin University, Sessional Academic at Victoria University and Victorian Clinical Director of Health Promotion for Special Olympics Australia. She is currently a Lecturer/Early Career Development Fellow in Nutrition at RMIT University.

 

Abstract:

Since the human genome has been sequenced there has been a revolution in our understanding of how genetic variation can considerably influence medical outcomes and responses to therapeutic interventions. Advancements in this field have been particularly prominent in the field of oncology, where developing tailored drug-based interventions for specific genetic alterations has led to remarkable therapeutic outcomes. The genomic revolution represents the next shift in how we treat people for various diseases by specifically tailoring their treatment based on their genetic background, including how diet affects our health. Not all people respond in the same way to different food and food patterns. This is influenced by an individual’s genetic make-up. Personalized nutrition recommendations by health professionals, which take genetic differences into account, will therefore become necessary to prevent and treat nutrition-related diseases, in contrast to conventional one-size-fits all recommendations. The ability to provide a person dietary advice, specific to their genetic make-up, is also complicated by other factors. This includes how environmental factors modify genes (epigenetics), the composition of good and bad bacteria (microbiome) in the gut and the levels of different metabolites in the blood. These factors together describe nutritional genomics and all must be taken into consideration when identifying genetic sub-groups who would benefit from particular dietary recommendations. The ultimate goal in this field is to integrate all of this information to ensure that health-care professionals, including nutritionist’s and dietitians, know enough about nutritional genomics to decide on the most appropriate level of care to achieve personalized nutrition. This presentation will discuss the adoption of nutritional genomics technologies in nutrition practice, focusing on current evidence, barriers and future directions.

 

Salvatore Avallone

Saint’Anne Military Hospital, France

Title: Title: Gut and microbiota why not with curcumin?

Time : 15:45-16:15

Biography:

Salvatore Avallone is the Surgeon at Saint’Anne Military Hospital, Toulon. Chef de Clinique Assistant Hospitalier' (surgeon,lecturer, research) Digestive and
Endocrine Surgery (Professor LEHUR P.A.), Hotel Dieu CHU Teaching Hospital, Nantes, Head of Unit A3, General Surgery and Gastrointestinal (GI) cancer, C.H.U. Teaching Hospital, NICE.

Abstract:

Nonalcoholic fatty liver disease (NASH) and non alcoholic fatty liver disease (NAFLD) are associated with changes in the intestinal microbiota. Dysbiosis can develop intestinal inflammation and alter the gut barrier. Microbial products reach the liver, induce hepatic inflammation and contribute to progression liver disease. The gut microbiota is an important factor in the regulation of metabolic pathways, the approaches are identified in chemical processes involving metabolites in patients with NASH and NAFDL. Altered metabolite patterns can serve as biomarkers, whereas specific metabolites have been identified with disease progression. A new therapeutic microbiome-based approaches can serve to treat NASH. We know in a well characterized adult population, that NASH was associated with reduced abundance of several bacterial taxa (Ruminococcus, Coprococcus and F. prausnitzii) independent of BMI (body mass index) and IR (insulin resistance) and higher concentrations of select fecal and serum metabolites, which may suggest a specific IM (intestinal microbiota) community and functional profile in these patients.

Vikas Leelavati Balasaheb Jadhav

Dr. D. Y. Patil University, India

Title: Transabdominal sonography of the small and large intestines

Time : 11:30-12:30

Speaker
Biography:

Vikas Leelavati Balasaheb Jadhav has completed PostGraduation in Radiology in 1994. He has a 23 Years of experience in the field of Gastro-Intestinal Tract Ultrasound & Diagnostic as well Therapeutic Interventional Sonography. He is the Pioneer of Gastro-Intestinal Tract Sonography, especially Gastro-Duodenal Sonography. He has delivered many Guest Lectures in Indian as well International Conferences in nearly 27 countries as an Invited Guest Faculty, since March 2000. He is a Consultant Radiologist & the Specialist in Conventional as well Unconventional Gastro-Intestinal Tract Ultrasound & Diagnostic as well Therapeutic Interventional Sonologist in Pune, India.

 

Abstract:

Transabdominal Sonography of the Small & Large Intestines can reveal following diseases. Bacterial & Viral Entero-Colitis. An Ulcer, whether it is superficial, deep with risk of impending perforation, Perforated, Sealed perforation, Chronic Ulcer & Post-Healing fibrosis & stricture. Polyps & Diverticulum. Benign intra-mural tumours. Intra-mural haematoma. Intestinal Ascariasis. Foreign Body. Necrotizing Entero-Colitis. Tuberculosis. Intussusception. Inflammatory Bowel Disease, Ulcerative Colitis, Cronhs Disease. Complications of an Inflammatory Bowel Disease – Perforation, Stricture. Neoplastic lesion is usually a segment involvement, & shows irregularly thickened, hypoechoic & aperistaltic wall with loss of normal layering pattern. It is usually a solitary stricture & has eccentric irregular luminal narrowing. It shows loss of normal Gut Signature. Enlargement of the involved segment seen. Shouldering effect at the ends of stricture is most common feature. Primary arising from wall itself & secondary are invasion from adjacent malignancy or distant metastasis. All these cases are compared & proved with gold standards like surgery & endoscopy. Some extra efforts taken during all routine or emergent ultrasonography examinations can be an effective non-invasive method to diagnose primarily hitherto unsuspected benign & malignant Gastro-Intestinal Tract lesions, so should be the investigation of choice.

 

Speaker
Biography:

Yerimova N Zh, Gastroenterologist of  Syzganov’s  National Scientific Center of  Surgery. Her research interest includes Gastroenterology, children liver transplantation and general pediatrics, scientific research, stem cell.

 

Abstract:

Aim: Evaluation of the effectiveness of the prevention of the treatment of cytomegalovirus infection after liver transplantation in children under 1 year of age with biliary atresia.

Material & Methods: Since March 2016 18 liver transplants from a living related donor in children were performed. The age of the patients ranged from 7 months to 8 years. Of these 15 (83.3%) patients were with biliary atresia. The number of girls is 10 (66.7%) and boys 5 (33.3%). At the time of diagnosis, most of the children registered formed cirrhosis of the liver.

Results: All recipients with positive quantitative parameters of PCR received CMV-specific immunoglobulin 3-5 months before the operation. The left lateral sector was transplanted to 15 patients with biliary atresia from CMV of the seropositive related lifelong donor (D+/R+) 13 donors and from CMV 1 seronegative donor (D-/R+), 1 to the simultaneous transplantation (liver and kidney) 2 patients with cirrhosis of the liver in the outcome of autoimmune hepatitis. In all children, biliary atresia was combined with a cytomegalovirus infection, 7 of them with an active form. The observation period is from 14 days after the operation to 2 years. After the operation, a three-component immunosuppressive therapy was performed (prednisolone, Sellsept, Tacrolimus). Activation was noted in 2 patients with inactive form of CMV. In 2 children, neurologic symptoms developed - 1 with active form of CMV and in 1 child it was associated with a toxic effect of immunosuppressive therapy (tacrolimus), which was managed by conservative methods of treatment. All children with cytomegalovirus infection received antiviral therapy with valganciclovir at a rate of 18 mg/kg for 1 month, against which the virus load in children with an active CMV phase was reduced. Six months after the operation, in all children, the quality of PCR for CMV was negative. At 9 months after liver transplantation, 1 patient with an inactive form of CMV had an increase in viral load.

Conclusions: Thus, our experience once again confirms the role of cytomegalovirus infection in the development of biliary atresia with the formation of liver cirrhosis and requires adequate follow-up after liver transplantation.

Speaker
Biography:

Derouiche Abdelfettah has received a PhD in Bio-industry from the University of Nancy France in 1988 and PhD in Human Nutrition in 2008, Hassan University II Casablanca Morocco. He is the Professor in Human Nutrition and is a Director of the human nutrition research unit. He is a Temporary adviser on nutrition of WHO and the Head of Moroccan action on salt and health (MASH).

 

Abstract:

Statement of the Problem: Non-communicable diseases (NCDs) are not just a public health problem, they are also economical. These diseases are accentuated in the part of the population facing economic challenges and often resulting from rural exodus. The results of the (NCD) screenings in the city of Casablanca Morocco showed a high frequency of obesity and possible undiagnosed cases of NCD in low and middle-income areas. This study aimed to evaluate the prevalence of obesity among women in Casablanca and to study the factors involved.

Method: A survey was conducted in six Casablanca neighborhoods using multi-stage cluster sampling. Anthropometric parameters and body composition were measured and information on the evolution of eating habits, socio-demographic status and body image perception and use of fattening products was collected using a questionnaire of 425 adult women from the neighborhoods of Casablanca.

Result: We found a prevalence of 47% obesity and 36% overweight. Obesity and overweight exceeded 80% in all age groups, except for women under 25, where we found a prevalence of 44% overweight. In addition, the prevalence of abdominal obesity was high in all age groups with an overall prevalence of 67%. Body image perception data showed that 62% of women perceived their weight as normal or insufficient, 46% of these women were, in fact, overweight or obese. Fattening products have been used at least once by 12% of the population, especially by women under 35 years of age.

Conclusion: The problem of overweight and obesity in this society exceeds twice the national prevalence it would be in addition to the change in eating behavior and lifestyle to the perception of a regular weight and the use of fattening substances.

 

 

 

 

Biography:

Abstract:

Jessica Danaher

Royal Melbourne Institute of Technology University, Australia

Title: Using nutritional genomics in nutrition practice: Current evidence and future directions
Speaker
Biography:

Abstract:

Speaker
Biography:

Yerimova N Zh, Gastroenterologist of  Syzganov’s  National Scientific Center of  Surgery. Her research interest includes Gastroenterology, children liver transplantation and general pediatrics, scientific research, stem cell.

 

Abstract:

Aim: Evaluation of the effectiveness of the prevention of the treatment of cytomegalovirus infection after liver transplantation in children under 1 year of age with biliary atresia.

Material & Methods: Since March 2016 18 liver transplants from a living related donor in children were performed. The age of the patients ranged from 7 months to 8 years. Of these 15 (83.3%) patients were with biliary atresia. The number of girls is 10 (66.7%) and boys 5 (33.3%). At the time of diagnosis, most of the children registered formed cirrhosis of the liver.

Results: All recipients with positive quantitative parameters of PCR received CMV-specific immunoglobulin 3-5 months before the operation. The left lateral sector was transplanted to 15 patients with biliary atresia from CMV of the seropositive related lifelong donor (D+/R+) 13 donors and from CMV 1 seronegative donor (D-/R+), 1 to the simultaneous transplantation (liver and kidney) 2 patients with cirrhosis of the liver in the outcome of autoimmune hepatitis. In all children, biliary atresia was combined with a cytomegalovirus infection, 7 of them with an active form. The observation period is from 14 days after the operation to 2 years. After the operation, a three-component immunosuppressive therapy was performed (prednisolone, Sellsept, Tacrolimus). Activation was noted in 2 patients with inactive form of CMV. In 2 children, neurologic symptoms developed - 1 with active form of CMV and in 1 child it was associated with a toxic effect of immunosuppressive therapy (tacrolimus), which was managed by conservative methods of treatment. All children with cytomegalovirus infection received antiviral therapy with valganciclovir at a rate of 18 mg/kg for 1 month, against which the virus load in children with an active CMV phase was reduced. Six months after the operation, in all children, the quality of PCR for CMV was negative. At 9 months after liver transplantation, 1 patient with an inactive form of CMV had an increase in viral load.

Conclusions: Thus, our experience once again confirms the role of cytomegalovirus infection in the development of biliary atresia with the formation of liver cirrhosis and requires adequate follow-up after liver transplantation.